Finance

Lists
DPHARMA:KLSE
Duopharma Biotech Bhd
MYR 1.14
-1.72%
(-0.020) 1D
Oct 2, 5:00:00 PM GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for DPHARMA...
Open
MYR 1.16
High
MYR 1.17
Low
MYR 1.14
Mkt. cap
1.10B
Avg. vol.
416.98K
Volume
432.60K
Dividend
3.99%
Quarterly dividend
MYR 0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.73
52-wk high
MYR 1.57
52-wk low
MYR 1.14
EPS
MYR 0.11
Shares outstanding
961.94M
No. of employees
2K
Open
MYR 1.16
High
MYR 1.17
Low
MYR 1.14
Mkt. cap
1.10B
Avg. vol.
416.98K
Volume
432.60K
Dividend
3.99%
Quarterly dividend
MYR 0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.73
52-wk high
MYR 1.57
52-wk low
MYR 1.14
EPS
MYR 0.11
Shares outstanding
961.94M
No. of employees
2K
News stories
From web sources and news partners
About Duopharma Biotech Bhd
CEO-
Employees2K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websiteduopharmabiotech.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
222.49M
224.69M
247.88M
234.36M
Cost of goods sold
131.74M
128.63M
150.58M
134.89M
Cost of revenue
131.74M
128.63M
150.58M
134.89M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.11M
64.37M
52.42M
55.74M
Operating expense
56.18M
66.90M
52.88M
55.60M
Total operating expenses
187.93M
195.53M
203.46M
190.50M
Operating income
34.56M
29.15M
44.42M
43.86M
Other non operating income
-
-590.00K
-
-
EBT including unusual items
29.68M
24.91M
40.41M
39.30M
EBT excluding unusual items
29.68M
24.90M
40.41M
39.30M
Income tax expense
7.11M
5.86M
9.69M
9.43M
Effective tax rate
23.96%
23.52%
23.99%
24.00%
Other operating expenses
76.00K
2.00M
468.00K
-130.00K
Net income
22.57M
19.05M
30.71M
29.87M
Net profit margin
10.14%
8.48%
12.39%
12.75%
Earnings per share
-
-
-
-
Interest and investment income
1.53M
1.52M
1.58M
1.34M
Interest expense
-6.40M
-5.19M
-5.60M
-5.89M
Net interest expenses
-4.88M
-3.67M
-4.02M
-4.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
45.74M
32.61M
55.43M
54.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps